Supporting the Approval of a Treatment for a Neglected Tropical Disease
In this video, Dr. Mark Sullivan, Managing Director of Medicines Development for Global Health, explains how Certara’s model-informed drug development expertise was used to support developing moxidectin as a treatment for onchocerciasis “river blindness.” Transcript The role that Certara has played has really been a as an as a integral part of our drug development … Continued
https://www.certara.com/video/supporting-the-approval-of-a-treatment-for-a-neglected-tropical-disease/